Pearl River Capital, LLC Jazz Pharmaceuticals PLC Transaction History

Pearl River Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$114.26 - $136.0 $579,640 - $689,928	-5,073 Reduced 66.0%	2,613 $321,000
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $649,284 - $773,339	5,322 Added 225.13%	7,686 $994,000
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $289,590 - $347,886	2,364 New	2,364 $293,000
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $414,066 - $510,241	3,192 Added 181.98%	4,946 $787,000
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $222,038 - $282,709	1,754 New	1,754 $234,000
Q4 2019 Feb 12, 2020	BUY	$117.65 - $153.73 $459,658 - $600,623	3,907 New	3,907 $583,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.